Embracing the Revolution: Insights from the ixlayer Webinar, Part 2
Key Takeaways from How Pharma Can Leverage At-Home Testing to Maximize Brand and Commercial Success ixlayer’s recent webinar, How Pharma Can Leverage At-Home Testing to Maximize Brand and Commercial...
View ArticleNew ixlayer Physician Survey Reveals Overwhelming Support for At-Home...
83% of U.S. physicians across specialties believe at-home diagnostic tests help move patients through the care continuum faster, leading to earlier diagnosis and treatment to support better health SAN...
View ArticleHCPs show cautious support for at-home diagnostic testing
This article was originally published in Medical Marketing and Media (MM+M). Overall, the vast majority of physicians support the incorporation of at-home diagnostic testing into the healthcare system....
View ArticleDoctors support growth of at-home testing, survey finds, opening new avenues...
This article was originally published by Fierce Pharma. Physicians don’t mind patients choosing at-home testing options over coming in for an in-person clinic visit—in fact, they overwhelmingly support...
View ArticleAt-Home Lab Testing: Understanding a Physician’s POV
A new ixlayer survey shows a growing consensus on the transformative potential of at-home diagnostic testing to revolutionize healthcare accessibility, physician workflow and patient engagement...
View ArticleThe Patient Journey is Now Digital
Direct-to-patient platforms, including telehealth, digital HCP connection, and multimodal diagnostic testing, have improved accessibility and convenience on their march to improved patient outcomes....
View Articleixlayer Launches ‘ixEngage’ a Direct-to-Patient Platform for Biopharma
‘ixEngage’ simplifies and accelerates the connection to care SAN FRANCISCO – September 11, 2024 – ixlayer, a healthcare technology platform serving biopharma, today unveiled ‘ixEngage’ – a...
View Article3 Takeaways from Our Discussion with Jessica Greig at Digital Pharma East 2024
3 minute read At this year’s Digital Pharma East, we had the pleasure of sitting down for a discussion with Jessica Greig, Head, Consumer Marketing Type 1 Diabetes Franchise at Sanofi, an expert in...
View ArticleWhy Pharma Should Buy, Not Build, a Direct-to-Patient Solution
We surveyed a group of pharmaceutical marketing executives, and over 50% are exploring or preparing a direct-to-patient (DTP) platform, á la LillyDirect and PfizerForAll. Launching successful DTP...
View ArticleComplete Blood Count Test with At-Home Sample Collection is Available for...
ixEngage removes barriers to care by accelerating pre-treatment and routine CBC tests used for hundreds of conditions, including asthma, heart disease and kidney disease SAN FRANCISCO – October 22,...
View Article